Geredeli, C. Et Al. 2015. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer. TUMOR BIOLOGY , vol.36, no.6 , 4279-4285.

Geredeli, C., ARTAÇ, M., Yildirim, S., Inal, A., Dede, I., Guler, T., ... Boruban, M. C.(2015). Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer. TUMOR BIOLOGY , vol.36, no.6, 4279-4285.

Geredeli, Caglayan Et Al. "Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer," TUMOR BIOLOGY , vol.36, no.6, 4279-4285, 2015

Geredeli, Caglayan Et Al. "Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer." TUMOR BIOLOGY , vol.36, no.6, pp.4279-4285, 2015

Geredeli, C. Et Al. (2015) . "Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer." TUMOR BIOLOGY , vol.36, no.6, pp.4279-4285.

@article{article, author={Caglayan Geredeli Et Al. }, title={Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer}, journal={TUMOR BIOLOGY}, year=2015, pages={4279-4285} }